24 documents found, page 1 of 3
Gene editing with CRISPR/Cas methodology and thyroid cancer: where are we?
Kimura, Edna Teruko
Targeting the highly expressed microRNA miR-146b with CRISPR/Cas9n gene editing...
Kimura, Edna Teruko
Genetic mutations and variants in the susceptibility of familial non-medullary ...
Kimura, Edna Teruko
Elemental characterization of oral cavity squamous cell carcinoma and its relat...
Kimura, Edna Teruko
How does microRNA modulate Wnt/β-catenin signaling in thyroid oncogenesis?
Kimura, Edna Teruko
Thyroid follicular cell loss of differentiation induced by MicroRNA miR-17-92 c...
Kimura, Edna Teruko
Expression of notch and nodal embryonic components in BRAF- and RAS-like thyroi...
Kimura, Edna Teruko
Interplay of TGFβ signaling and microRNA in thyroid cell loss of differentiatio...
Kimura, Edna Teruko
The highly expressed FAM83F Protein in papillary thyroid cancer exerts a pro-on...
Kimura, Edna Teruko
Osteoglycin post-transcriptional regulation by miR-155 induces cellular archite...
Oliveira, Grasieli de [UNESP]; Freire, Paula Paccielli [UNESP]; Mieko Omoto, Ana Carolina [UNESP]; Cury, Sarah Santiloni [UNESP]; Fuziwara, Cesar SeigiMade available in DSpace on 2019-10-04T12:30:54Z (GMT). No. of bitstreams: 0 Previous issue date: 2018-11-15; Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); Several studies have demonstrated dysregulated cardiac microRNAs (miRNAs) following cardiac stress and development of cardiac hypertrophy and failure. miRNAs are also differentially expressed in the inflammation that occurs in heart failure ...